NovaGo Logo
Arrow
Arrow
Slider
Arrow
Arrow
Slider

Who we are

NovaGo Therapeutics is a development stage biotech company focused on human antibody therapeutics targeting blood vessel and nerve growth.

read more

DIABETIC RETINOPATHY

NovaGo is planning to initiate clinical development for its lead molecule as a novel treatment for diabetic retinopathy (DR), the leading cause of blindness in adults. DR is a common complication of Type 1 and Type 2 Diabetes.

read more

News

NovaGo appoints Ian Metcalfe as CEO

read more